141O Efficacy outcomes by age from 5 observational or phase-4 studies of bevacizumab (Bev) in metastatic colorectal cancer (mCRC)

Autor: Hubbard, J., Grothey, A., Van Cutsem, E., Hurwitz, H., Kozloff, M.F., Bekaii-Saab, T., Bennouna, J., Zafar, Y., Revil, C., Sommer, N., Srock, S., Arnold, D.
Zdroj: In Annals of Oncology 1 December 2015 26 Supplement 9:ix42-ix42
Databáze: ScienceDirect